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Background: The majority of patients suffering from cluster headache (CH) are smokers and it has been suggested
that smoking may trigger the development of CH. The aim of this pilot survey was to describe: 1. the differences
between current, former, and never smokers CH patients; 2. if smoking changed during an active cluster period;
3. if CH changed after quitting.
Methods: All outpatients with episodic CH according to the criteria of ICHD-II who were consecutively seen for the
first time from October 2010 to April 2012 at a headache centre were interviewed by phone using a specifically
prepared questionnaire. Statistical differences between continuous variables were analysed by the Student’s t-test or
the one-way analysis of variance (ANOVA), followed by Newman-Keuls post-hoc testing. Comparisons between
percentages were made using the Chi-square test or Fisher’s exact test. All data were expressed as the mean ±
standard deviation (SD).
Results: Among a total of 200 patients surveyed (172 males, 28 females; mean age ± SD: 48.41 ± 12 years) there
were 60%, 21%, and 19% of current, former, and never smokers, respectively. Current smokers reported longer
active periods (12.38 ± 10 weeks) and a higher maximum number of attacks per day (3.38 ± 1) compared to never
smoker CH patients (5.68 ± 4 weeks, P <0.05 and 2.47 ± 1, P <0.05, respectively). During the active period most of
the patients stated to decrease (45.7%) or not to change (45.7%) the number of cigarettes smoked. Among those
who decreased smoking, most (83.8%) reported that they had less desire to smoke. After quitting, the majority of
former smokers stated that their headache had not changed.
Conclusions: Patients with episodic CH who are also smokers appear to have a more severe form of the disorder.
However, it is unlikely that between CH and smoking there is a causal relationship, as CH patients rarely improve
quitting smoking.
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The pathophysiology of cluster headache (CH), a very
severe form of primary headache [1], is not yet fully
known [2]. It is assumed that the activation of the pos-
terior hypothalamus and the trigeminovascular system is
involved [3] and probably genetic [4] and environmental
factors are also important [5]. Among the latter, tobacco
usage has always been consistently identified as associ-
ated with CH [6-8]. Indeed, most of CH patients, up to* Correspondence: anna.ferrari@unimore.it
1Headache and Drug Abuse Inter-Department Research Centre, Division of
Toxicology and Clinical Pharmacology, University of Modena and Reggio
Emilia- Policlinico, Largo del Pozzo, 71-41100, Modena, Italy
Full list of author information is available at the end of the article
© 2013 Ferrari et al.; licensee Springer. This is a
Attribution License (http://creativecommons.or
in any medium, provided the original work is p90% of males and about 70% of females, are smokers [9].
This high prevalence of smokers, greater than in the
general population [7], supports the possibility that
smoking may trigger the development of CH [10-12]. In
favour of a causal relationship between smoking and
CH, it has been observed that in most cases the onset of
the smoking habitus precedes the beginning of CH
[6,8,13-15] and that the prolonged exposure to second
hand smoke during childhood may trigger CH even in
non-smokers [12,16]. Moreover, CH develops earlier in
people living with smoking parents [12]. The exposure
to secondary smoke of parents could have an even more
important role in causing CH in women, among whichn Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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The number of women with CH is increasing and one of
the possible causes of this trend could be the rising
prevalence of smoking among women [9,14,16,17]. Fi-
nally, just the decline of the epidemic of smoking in
Minnesota was considered a factor that has helped re-
duce the incidence of CH from 1979 to 1990 [15].
The significance of the association with smoking for
the pathophysiology of CH remains unclear. Nicotine
and/or other toxic agents present in tobacco-based
products may cause CH acting directly on the hypotha-
lamus [12]. Smoking could trigger the activation of the
trigeminal autonomic reflex at the level of the brainstem,
causing precisely the cranial autonomic symptoms typ-
ical of CH [18]. If CH was triggered and/or worsened by
smoking, then the fight against cigarette smoking and
the interventions to help patients quit smoking would
become priority to reduce respectively the incidence of
CH and the patients’ suffering.
One of the strongest proofs to establish the existence
of a causal link between a substance and an event is its
decrease/disappearance by discontinuing the intake of
the substance. In fact, several diseases caused by smok-
ing improve quickly if the patient stops smoking. How-
ever, the impact of continuing or quitting smoking on
the clinical presentation and the time course of CH has
not been much studied. Thus, the purpose of our pilot
survey was to describe, by means of a questionnaire
administered by telephone, the impact of the smoking
status on episodic CH patients consecutively seen at a
headache centre, exploring: 1. the differences between
current, former, and never smokers; 2. if the mode of
smoking changed in current smokers during an active
cluster period 3. if CH had changed in former smokers
after they had stopped smoking.Methods
Patients
We enrolled all female and male outpatients, of all ages,
consecutively examined at the Headache Centre of the
University Hospital of Modena at a first visit from October
2010 to April 2012. We only included patients who had
been diagnosed episodic cluster headache according to the
criteria of the International Classification of Headache
Disorders, 2nd edition (ICHD-II) [1]. A total of 207 pa-
tients were found and they represented 7.2% of the 2881
patients globally examined for the first visit in the period
of the study. All patients were asked, during the visit, their
written informed consent to take part in the survey; none
of them refused to give it. However, it was impossible to
contact 7 patients. Our sample consisted therefore of 200
episodic cluster headache patients. The study was ap-
proved by the Ethical Committee of Modena and it wasconducted in compliance with the Declaration of Helsinki,
latest version.
Questionnaire and procedures
A questionnaire was prepared for the study. It included
a demographic section and a section investigating the
characteristic of CH (age of onset, frequency and length
of active periods, and maximum number of attacks/day
in the active period) and whether patients were current,
former or never smokers. Those who declared them-
selves current or former smokers were asked to specify
the age of onset of smoking, the number of cigarettes
smoked at the beginning and presently, and if in the ac-
tive period of CH their mode of smoking increased, de-
creased or was unchanged and why. Former smokers
were asked how long before they had quit smoking and
if this had increased, decreased or unchanged the char-
acteristics of the headache (frequency and duration of
the active periods, maximum number of attacks per day,
length and intensity of the single attack).
Before being administered, the questionnaire had been
tested among the patients seen at the outpatients’ ward
of the Headache Centre in July, August, and September
2010. The questionnaire was administered during a
phone interview by a trained postgraduate medical doc-
tor who had never examined the patients before.
Data analysis
The data collected by the questionnaire were inserted into
a specially prepared data-base. A descriptive analysis of all
collected parameters was made. In order to compare the
three groups defining smoking status (current, former, and
never smokers) in terms of continuous variables (such as
age, age of disease onset, length of CH, length of active pe-
riods, and maximum number of attacks/day), means and
standard deviations (SD) for each group were calculated
and the one-way analysis of variance (ANOVA) was
conducted, followed by Newman-Keuls post-hoc testing.
In terms of categorical variables (such as sex, level of edu-
cation, occupation status, marital status, and number of
active periods), counts and percentages for each group
were obtained and a Chi-square test or a Fisher’s exact test
was conducted. For multiple comparison, a Bonferroni
correction was carried out and a P value < 0.025 was
considered significant. Moreover, a comparison was made
between female and male episodic CH patients.
In order to compare current and former smokers in
terms of continuous variables (such as age of onset of
smoking, length of smoking, number of cigarettes/day
smoked at the onset of CH, and number of cigarettes/day
smoked at the time of completing the questionnaire),
means ± SD were calculated between groups and the Stu-
dent’s t-test was carried out. In terms of categorical vari-
ables (such as patients who start smoking before the onset
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creased, decreased or unchanged - during the active
period), counts and percentages for each group were
obtained and a Chi-square test or a Fisher’s exact test was
conducted. A P-value < 0.05 was considered significant.
Results
Current smokers represented 60% of the sample, former
smokers 21%, and never smokers 19%. Males were the
majority of the sample. Overall, the M/F ratio was
6.14:1; the ratio was not similar among the three groups
(P < 0.05): it did not statistically differ between current
smokers and never smokers (respectively 5.66:1 and
2.8:1), but it was statistically different between former
smokers and the other two groups, because there were
no women among former smokers.
The mean age (Table 1) was similar among current,
former, and never smokers. Women were significantly
older (54.21 ± 8.15 years) than men (47.46 ± 11.9 years)
(P < 0.05). More than half of the sample (55%) had at
least a diploma. Former and never smokers were gener-
ally more educated than current smokers (respectively
66.8% and 63.1% versus 48.4% with at least a diploma).
The percentage of graduates was significantly higher
among women (35.7%, n = 10/28) than among men
(15.1%, n = 26/172, P < 0.05). The majority of the sam-
ple (80%) worked, with no differences between females
(n = 20/28, 71.4%) and males (n = 140/172, 81.4%). SixtyTable 1 Demographic data
Variable Total (n = 200) Current smokers (n =
Mean age ± SD (years) 48.41 ± 12 47.91 ± 11
Range 25 - 85 25 - 85
N. % N. %
Females 28 14 18a 15
Males 172 86 102 85
Education
Primary school 20 10 8 6.6
Middle school 70 35 54e 45
High school 74 37 40a 33
University degree 36 18 18 15
Occupation
Employed 160 80 94 78
Housewife 2 1 2 1.7
Retired person 28 14 14 11
Unemployed 10 5 10 8.3
Marital status
Living with a partner 120 60 70a 58
Living alone 80 40 50 41
a Current vs. former smokers: P < 0.025; b Former vs. never smokers: P < 0.001; c Ne
Current vs. never smokers: P < 0.025, Chi-square test with Bonferroni correction.percent of the patients were living with a partner/spouse,
with no difference between females (n = 12/28, 42.8%)
and males (n = 106/172, 61.6%).
On average, CH began around 30 years (Table 2), with
no differences by gender (age of onset of CH, females:
32 ± 18.5, males: 29.45 ± 12.6). The average length of
CH was around 18 years and there were no differences
between females (22.21 ± 12, range 7–35 years) and
males (18.3 ± 10.8, range 1–58 years). Current smokers
reported longer active periods and a higher maximum
number of attacks than never smokers (P < 0.05,
ANOVA followed by Newman-Keuls post-hoc testing).
The length of the active period was similar between fe-
males (12.36 ± 11.07 weeks) and males (12.03 ± 10.8
weeks) and also the maximum number of attacks per
day did not vary by gender (females: 3.14 ± 1.9; males:
3.26 ± 2.3). About a third of the sample, with no differ-
ences between males and females, had one or more ac-
tive periods each year; another third had periods of
remission exceeding one year; in the remaining, the fre-
quency of active periods was erratic.
Smokers (current and former) (Table 3) had started
smoking on average around 17 years and had continued
for at least 26 years. There were no differences by gender
in terms of age of smoking onset (females: 19.33 ± 7 years,
males: 16.76 ± 2.7 years) and in the duration of the smok-
ing habit (females: 32.55 ± 10.3 years, males: 31.54 ± 11.3
years). The vast majority of the patients had started120) Former smokers (n = 42) Never smokers (n = 38)
50.95 ± 12 47.16 ± 16
32 - 78 30 - 81
N. % N. %
0 0 10 26.3
42b 100 28 73.7
2 4.7 10c, d 26.3
12 28.5 4 10.6
.4 24 57.3 10d 26.3
4 9.5 14d, e 36.8
.3 36 85.7 30 78.9
0 0 0 0
.7 6 14.3 8 21.1
0 0 0 0
.3 14 33.3 22 57.9
.7 28 66.7 16 42.1
ver vs. current smokers: P < 0.025; d Never vs. former smokers: P < 0.025; e
Table 2 Characteristics of episodic cluster headache in current, former, and never smokers patients
Variable Total (n = 200) Current smokers (n = 120) Former smokers (n = 42) Never smokers (n = 38)
Mean ± SD Range Mean ± SD Range Mean ± SD Range Mean ± SD Range
Age of onset (years) 29.81± 13 11 - 74 29.63 ± 12 11- 65 28.66 ± 13 15 - 74 31.63 ± 17 16 - 72
Length of CH (years) 18.6 ± 11 1 - 49 18.28 ± 9 2 - 40 22.28 ± 12a 4 - 58 15.52 ± 13 1 - 49
Length of active period (weeks) 10.24 ± 8 1 - 40 12.38 ± 10b 2 - 40 8.24 ± 7 1 - 40 5.68 ± 4 1 - 20
Maximum number of attacks/day 3.14 ± 1 1 - 8 3.38 ± 1c 1 - 8 3.04 ± 2 1 - 8 2.47 ± 1 1 - 6
N. of active period N. % N. % N. % N. %
1/year 38 19 26 22 0 0 12 31
>1/year 27 13.5 17 14 4 10 6 16
<1/years 72 36 43 36 17 40 12 32
Erratic 63 31.5 34 28 21d 50 8 21
a Former vs. current and vs. never smokers: P < 0.05; b Current vs formers vs. and vs. never smokers: P < 0.05; c Current vs. never smokers: P < 0.05, ANOVA
followed by Newman-Keuls post-hoc testing; d Former vs. current and vs. never smokers: P < 0.025, Chi-square test with Bonferroni correction.
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ference between females (n = 18/18, 100%) and males (n =
132/150, 91.7%). At the onset of CH, patients smoked an
average of 17 cigarettes per day; males smoked more in-
tensively (18.39 ± 8.5 cigarettes/day) than females (13.22 ±
6.8 cigarettes/day) (P < 0.05). At the time of the interview,
the number of cigarettes/day that current smokers claimed
smoking had not significantly increased and was similar
between females (15.11 ± 8.2 cigarettes/day) and males
(17.33 ± 8.4 cigarettes/day). Former smokers, all males,
had stopped smoking 8.4 ± 6.8 years before on average
(range 1–35 years); in particular, 69% (n = 29/42) of the
sample had quit it over 5 years before. During the active
period of CH, most patients stated whether to decrease or
not to change the number of cigarettes smoked; only a
small portion claimed to increase it (8.6%). This pattern
was similar between females (decreased: n = 12/18, 66.7%;
did not change: n = 6/18, 33.3%; increased: n = 0/18) andTable 3 Characteristics of smoking status of episodic cluster h
Total (n = 162)
Mean ± SD Range
Age of onset of smoking (years) 17.04 ± 3 12 - 38
Length of smoking (years) 29.56 ± 11 2 - 55
N. of cigarettes/day smoked at the
onset of cluster headache
17.74 ± 8 1 - 60
N. of cigarettes/day smoked at the
time of completing the questionnaire
16.98 ± 8 1 - 35
N %
Patients who start smoking before the
onset of cluster headache
150 92.6




a Current vs. former smokers: P < 0.05, Student’s t-test for unpaired data; b Increased
Bonferroni correction.males (decreased: n = 63/144, 43.75; did not change:
n = 67/144, 46.52%; increased: n = 14/144, 9.8%). Those
who did not change the number of smoked cigarettes de-
clared that smoking had no influence on their CH. Among
those who decreased smoking, the majority (n = 62/74,
83.8%) reported that they had less desire to smoke and the
others (n = 12/74, 16.2%) said that smoking made them
feel worse, by increasing the intensity of pain. The few pa-
tients who increased smoking said that it made their pain
more bearable, relieving agitation. There were no differ-
ences by gender in the distribution of the reasons to re-
duce, not to vary or increase the number of cigarettes
smoked during the active period of CH.
After they had stopped smoking (Figure 1), most
former smokers reported that their headache had not
changed. In particular, the patients who did not report
any change in the length of the active phase (n = 28/42,
66.7%), the maximum number of attacks/day (n = 32/42,eadache patients who were current and former smokers
Current smokers (n = 120) Former smokers (n = 42)
Mean ± SD Range Mean ± SD Range
17.16 ± 3 12 - 38 16.71 ± 2 13 - 22
30.75 ± 10a 11 - 49 26.19 ± 13 2 - 55
17.50 ± 9 1 - 60 17.77 ± 6 6 - 30
16.98 ± 8 1 - 35 0 0
N % N %
111 92.5 39 92.85
12b 10 2b 5
58 48.3 16 40
50 41.7 24 55

















Length of attack Intensity of attack















Figure 1 Changes in the characteristics of episodic cluster headache that were reported by 42 former smokers after they had
quit smoking.
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the single attack (n = 36/42, 85.8%) were more than
those who stated a reduction of these variables (length
of the active period: n = 10/42, 23.8%; number of at-
tacks/day: n = 6/42, 14.3%; intensity: n = 12/42, 28.6%;
length of the single attack: n = 6/42, 14.3%). A minority
of patients reported an increase in the length of the ac-
tive period (n = 4/42, 9.5%), the number of attacks/day
(n = 4/42, 9.5%), and the intensity of the attack (n = 4/
42, 9.5%). Nine out of 42 (22%) declared an increase, 19/
42 (45%) a reduction, and 14/42 (33%) no change as far
as the frequency of active periods is concerned.
Discussion
The results of our survey indicated that the smoking sta-
tus was associated with a more severe phenotype of CH
than that of patients who had never smoked. In fact,
current smokers reported longer active periods and a
higher maximum number of attacks per day compared
to never smoker CH patients (P < 0.05). Most studies in
pain populations find that smoking is related to more
pain and greater pain intensity compared to people who
never smoked [19,20]. The reasons for this relationship
are not clear. Experimental studies in human models of
pain suggest that nicotine has analgesic properties
[21,22]. However, epidemiological and clinical data show
that smoking is a risk factor for chronic pain [23,24].
The finding from current study that former smokers
were indistinguishable from never smokers with respect
to the length of active periods and the maximum number
of attacks per day further strengthens the many reasonswhy quitting smoking may be beneficial. Given the high
smoking rate among CH patients, providing smoking ces-
sation assistance would likely be a valuable addition to
treatment.
Patients with pain who are smokers use smoking to
manage pain-related emotional distress and as a distracter
from pain [25]. Up to 93% of patients with CH report a
sense of agitation and restlessness during the attack
[7,26,27]. Despite this, most patients said that, during ac-
tive periods, they did not change smoking or smoked less
because their desire to smoke decreased (83.8%) or
because smoking worsened pain (16.2%). Maybe this aver-
sive effect was partly caused by the symptoms of cranial
autonomic activation, such as lacrimation, nasal conges-
tion, and/or rhinorrhea, which are present in the vast ma-
jority of patients [11,27], and may have made quite
unpleasant to smoke. Other symptoms, often present dur-
ing the attack, such as discomfort for strong smells, nau-
sea and vomiting [7,27], may have contributed to reduce
smoking or prevented from smoking more to relieve
restleness. The behaviour of smokers during active periods
of CH has not been much studied. In part, our results
confirm what has been reported in a study involving 49
patients with CH: namely, while most patients reduce al-
cohol intake in active phase, they do not change tobacco
use [6]. A recent survey shows that only 27% of patients
use cigarettes to relax during or after an attack [8].
It is very unlikely that the association between smok-
ing and CH is a causal relationship. Differently from
other diseases caused by smoking, CH had not improved
in most patients who had stopped smoking years before
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an Internet-based survey finds that only 3% of CH pa-
tients have an improvement after quitting smoking [28].
There is probably no correlation between smoking cessa-
tion and changes in the course of CH [15].
The present study does not allow clarifying the signifi-
cance of the association between smoking and CH. It has
been suggested that in CH patients the smoking habitus
could represent a personality/style-related characteristic
[6,29,30]. Differently, it has been speculated that there is a
genetic link that predisposes people with CH to nicotine
addiction [7]. Moreover, CH patients might be biologically
more vulnerable to compulsive pursuit of legal and illegal
substances for a partial overlap/sharing of pathways which
mediate addiction and are involved in the pathophysiology
of CH. Indeed, changes in the prefrontal cortex have re-
cently been found in CH patients [31,32], but dysfunction
in prefrontal cortex is also involved in drug addiction [33].
Orexin neuropeptide systems have been suggested to have
an important role in both CH pathogenesis [34] and the
regulation of the reinforcing properties of most major
drugs of abuse [35], including nicotine [36]. A support of
this hypothesis is that patients suffering from CH have a
greater prevalence of the use of illicit drugs compared to
healthy controls [37].
The results of our investigation are similar to those in
literature [6,11,13,14,27,38,39] with regard to the preva-
lence of males and smokers, the long duration of the dis-
order, and the data indicating that the majority of patients
(over 90%) began to smoke before the beginning of CH. In
Italy there has been a decline of smoking prevalence for
both sexes since 1990 [40]. In 2002, 27.6% of the popula-
tion reported to be current smoker, while in 2012 this per-
centage had declined to 20.8% (females: 17.2%, males:
24.6%) of the population [41]. Perhaps this trend explains
why the percentage of current smokers (60%) in our study
was lower and those of former (21%) and never smokers
(19%) higher than in other studies: a survey in Germany
between 2002 and 2004 found that current, former, and
never smokers among CH patients were respectively
65.9%, 14.2%, and 19.9% [7]. In the same country, there
were 68% of current smokers, 19% of former, and 13% of
never smokers between 2009 and 2010 [39]. In another
survey, carried out in France in 2005, current smokers
were 68%, former smokers 19%, and never smokers 12%
[11].
Overall, episodic CH seems to appear in a similar way
between females and males [42]. There were no striking
differences by gender in the variables that we investi-
gated. As reported by a survey in the United States [42],
there were significantly more women than men among
patients with CH who had never smoked (P < 0.005,
Fisher's exact test). Differently from this study [42], we
found that the probability of never having smoked beforethe start of CH was similar between females and males,
not higher among females. This discrepancy may be due
to having conducted the survey among patients of a spe-
cialist centre and to the limited number of women in our
sample. Male/female ratio is higher in clinical population
than in the general population [43]. In the total sample,
the M/F ratio was similar to that detected in another
Italian study that involved clinical cases series [43].
Our research has some limits. It was carried out
among a consecutive series of episodic CH patients seen
for a first visit at a specialist centre and the findings can-
not be generalised to other patients and settings. In par-
ticular, we cannot exclude that there are patients whose
cluster headache has completely resolved by quitting
smoking and therefore they do not need to seek medical
attention. However, if quitting smoking had a decisive
impact to improve cluster headache, this effect should
apply to all patients with this disorder. The patients who
participated in our pilot survey had the typical charac-
teristics of cluster headache and they had received a pre-
cise diagnosis of episodic CH according to the ICHD-II
classification [1] by a specialist of the headache centre.
We assessed the impact of smoking on CH asking the
patients’ opinion, which is subject to potential recall
bias. The true natural history of cluster headache is very
difficult to determine. A prospective study in patients
with chronic cluster headache could possibly provide
relatively more objective data. Nevertheless, nobody can
say better than the patient if his/her health has or has
not improved after a change in lifestyle with respect to
the prior condition. Moreover, we cannot exclude that
some former smokers continued to be exposed to
second-hand smoke. Considering that the majority of
patients worked (in Italy it is forbidden to smoke in pub-
lic and private workplaces) and nearly 67% lived alone, it
is unlikely that this second-hand smoke exposure was
relevant. Finally, there are no data showing that CH pa-
tients’ opinion is unreliable. On the contrary, they have
been considered to report information accurately [7].
To the best of our knowledge, this is the first study
that has specifically described whether and how smoking
impacts on CH comparing former to current and never
smoker patients.Conclusions
The results of our pilot survey show that CH patients who
are also smokers have a more serious disorder. These re-
sults provide one more reason to advise patients to quit
smoking. However, it is important not to blame the pa-
tients, since it is unlikely that their CH has been caused by
smoking. Indeed, according to most patients’ judgment,
quitting smoking has hardly ever any impact on the clin-
ical course of CH.
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